1. Market Research
  2. > Biotechnology Market Trends
  3. > Taiyen Biotech Co., Ltd - Company Profile and Financial Analysis

Summary
Canadean's "Taiyen Biotech Co., Ltd - Company Profile and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Taiyen Biotech Co., Ltd"

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
- Identifies crucial company information about "Taiyen Biotech Co., Ltd" along with major products and services for business intelligence requirements.

- Provides key ratios on company's financial performance.

- Identifies key employees to assist with key business decisions.

- Provides annual and interim financial ratios.

Reasons To Buy
- Enhance your understanding of "Taiyen Biotech Co., Ltd"

- Increase business/sales activities by understanding customers' businesses better.

- Recognize potential partnerships and suppliers.

- Qualify prospective partners, affiliates or suppliers.

- Acquire up-to-date company information and an understanding of the company's financial health.

Key Findings
Taiyen Biotech Co., Ltd. (Taiyen Biotech) is a manufacturer and supplier of health and beauty products. The company's product portfolio comprises bottled water, salts and seasonings, skincare products, cosmetics, health food, facial and body cleansers, dietary supplements, personal cleaning and salt sculptures. It also provides seasonings, snack foods, soaps, aluminum nitride products and biomedical products. Taiyen Biotech markets its products throughout Taiwan, China, Macau and Hong Kong. It operates through its facilities located in Taipei City, Hualien City, Taichung City, Kaohsiung City and Tainan, Taiwan; and Xiamen, China. The company distributes its products to China and the US. Taiyen Biotech is headquartered in Tainan, Taiwan.

Table Of Contents

Taiyen Biotech Co., Ltd - Company Profile and Financial Analysis
Table of Contents
1 Taiyen Biotech Co., Ltd
2 Taiyen Biotech Co., Ltd - Key Employees
3 Taiyen Biotech Co., Ltd - Major Products and Services
4 Taiyen Biotech Co., Ltd - Key Events
5 Taiyen Biotech Co., Ltd - Locations and Subsidiaries
5.1 Taiyen Biotech Co., Ltd - Head Office
6 Taiyen Biotech Co., Ltd - Business Analysis
6.1 Taiyen Biotech Co., Ltd - Company Overview
7 Taiyen Biotech Co., Ltd - Company Financial Analysis
7.1 Taiyen Biotech Co., Ltd - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
8 Taiyen Biotech Co., Ltd - Interim ratios
8.1.1 Taiyen Biotech Co., Ltd - Financial ratios: Capital Market Ratios
8.2 Taiyen Biotech Co., Ltd - Financial Performance and Ratio Charts
8.2.1 Taiyen Biotech Co., Ltd - Revenue and Operating margin
8.2.2 Taiyen Biotech Co., Ltd - Asset and Liabilities
8.2.3 Taiyen Biotech Co., Ltd - Operational Efficiency
8.2.4 Taiyen Biotech Co., Ltd - Valuation
8.3 Taiyen Biotech Co., Ltd - Competitive Benchmarking
8.3.1 Taiyen Biotech Co., Ltd - Market Capitalization
8.3.2 Taiyen Biotech Co., Ltd - Efficiency
8.3.3 Taiyen Biotech Co., Ltd - Valuation
8.3.4 Taiyen Biotech Co., Ltd - Turnover: Inventory and Asset
9 Appendix
9.1 Methodology
9.2 Taiyen Biotech Co., Ltd - Ratio Definitions
9.3 Disclaimer

List of Tables
Table 1: Taiyen Biotech Co., Ltd - Key Employees
Table 2: Taiyen Biotech Co., Ltd - Major Products and Services
Table 3: Taiyen Biotech Co., Ltd - Key Events
Table 4: Taiyen Biotech Co., Ltd - Annual ratios
Table 5: Taiyen Biotech Co., Ltd - Interim ratios
Table 6: Taiyen Biotech Co., Ltd - Capital Market Ratios

List of Figures
Figure 1: Taiyen Biotech Co., Ltd - Revenue and Operating Profit
Figure 2: Taiyen Biotech Co., Ltd - Asset and Liabilities
Figure 3: Taiyen Biotech Co., Ltd - Operational Efficiency
Figure 4: Taiyen Biotech Co., Ltd - Valuation
Figure 5: Taiyen Biotech Co., Ltd - Market Capitalization
Figure 6: Taiyen Biotech Co., Ltd - Efficiency
Figure 7: Taiyen Biotech Co., Ltd - Valuation
Figure 8: Taiyen Biotech Co., Ltd - Turnover: Inventory and Asset

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2016

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cellular Tumor Antigen p53 (Tumor Suppresso ...

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic ...

Tetanus - Pipeline Review, H2 2016

September 2016 $ 2000

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.